Endologix – In 2011 continued to capture market share
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative medical devices for the treatment of aortic disorders, today announced financial results for the three and twelve months ended December 31, 2011. John McDermott, Endologix President...